- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05587218
Recognition of Second Language Spoken Words, Signs, and Characters Via Perception and Production in Adults
October 17, 2022 updated by: University of Alabama, Tuscaloosa
How Motor Cortex Supports L2 Acquisition of Spoken Words, Signs, and Characters Via Perception and Production
Self-production facilitates acquisition of spoken words, signs, and characters from an unfamiliar second language.
The proposed work investigates how motor cortex, a key part of the brain enabling body action, supports their acquisition via production as well as perception, providing insight into whether they are learned via mental simulation of the body actions used to produce them.
It is hypothesized that activity in motor cortex will differ based on the body part used to produce lexical items (e.g., mouth vs. hands), will be greater for lexical items learned via production than observation, and will differentiate lexical items recognized successfully vs. unsuccessfully.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Laura Morett, Ph.D.
- Phone Number: 205-348-8489
- Email: lmorett@ua.edu
Study Locations
-
-
Alabama
-
Tuscaloosa, Alabama, United States, 35487
- University of Alabama, Tuscaloosa
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 33 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Right-handed
- Native English speaker
Exclusion Criteria:
- Knowledge of sign language or languages with logographic characters
- Hearing or vision impairments
- Speech, language, or learning disorders
- Unsecured metal body implants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Self-production
L2 lexical items self-produced at learning
|
After participants learn L2 lexical items via hearing or observing them paired with L1 translations, they are prompted to produce them themselves
|
Active Comparator: Perception
L2 lexical items heard or observed an additional time at learning
|
After participants learn L2 lexical items via hearing or observing them paired with L1 translations, they are prompted to produce them themselves
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Functional activity in motor cortex location, 5 min, recognition
Time Frame: 5 minutes after learning
|
Location of Blood Oxygen Level Dependent (BOLD) signal in motor cortex at recognition
|
5 minutes after learning
|
Functional activity in motor cortex degree, 5 min, recognition
Time Frame: 5 minutes after learning
|
Degree of Blood Oxygen Level Dependent (BOLD) signal in motor cortex at recognition
|
5 minutes after learning
|
Functional activity in motor cortex location, 1 week, recognition
Time Frame: 1 week after learning
|
Location of Blood Oxygen Level Dependent (BOLD) signal in motor cortex at recognition
|
1 week after learning
|
Functional activity in motor cortex degree, 1 week, recognition
Time Frame: 1 week after learning
|
Degree of Blood Oxygen Level Dependent (BOLD) signal in motor cortex at recognition
|
1 week after learning
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Laura Morett, Ph.D., University of Alabama, Tuscaloosa
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 23, 2023
Primary Completion (Anticipated)
May 8, 2026
Study Completion (Anticipated)
May 8, 2026
Study Registration Dates
First Submitted
September 30, 2022
First Submitted That Met QC Criteria
October 17, 2022
First Posted (Actual)
October 20, 2022
Study Record Updates
Last Update Posted (Actual)
October 20, 2022
Last Update Submitted That Met QC Criteria
October 17, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- L2WordProd
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
All individual participant data (IPD) underlying results in publications (de-identified)
IPD Sharing Time Frame
Immediately upon publication
IPD Sharing Access Criteria
Publicly available
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Second Language Acquisition in Healthy Young Adults
-
Fondation Ophtalmologique Adolphe de RothschildRecruiting
-
Escola Superior de Tecnologia da Saúde do PortoNot yet recruitingHealthy Young AdultsPortugal
-
Riphah International UniversityCompletedHealthy Young AdultsPakistan
-
Georgia Institute of TechnologyNational Institute of Neurological Disorders and Stroke (NINDS)CompletedHealthy Young AdultsUnited States
-
Touro University NevadaCompleted
-
Charite University, Berlin, GermanyCompleted
-
University of California, Los AngelesCompleted
-
Charite University, Berlin, GermanyPhysikalisch-Technische Bundesanstalt Institut Berlin (PTB)CompletedHealthy Young AdultsGermany
-
University of RochesterCompleted
-
National Taiwan Normal UniversityNot yet recruiting
Clinical Trials on Self-production
-
Idaho State UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)Active, not recruitingSpeech Sound DisorderUnited States
-
VA Office of Research and DevelopmentCompletedStroke | Aphasia | Apraxia of SpeechUnited States
-
Cornell UniversityCommunity Markets for Conservation (COMACO)CompletedMalnutrition, Child | Malnutrition, InfantZambia
-
Vanderbilt University Medical CenterRecruitingChronic Stroke | Weakness, MuscleUnited States
-
VA Office of Research and DevelopmentCompletedStroke | AphasiaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneUniversity of LyonRecruitingSelf-PerceptionFrance
-
Montclair State UniversityNew York University; National Institute on Deafness and Other Communication... and other collaboratorsRecruiting
-
VA Office of Research and DevelopmentCompleted
-
University of British ColumbiaCompleted
-
Medical College of WisconsinRecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Central Nervous System Lymphoma | Mantle Cell Lymphoma (MCL) | Non Hodgkin Lymphoma (NHL)United States